Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > Camptothecin

Camptothecin : Research Triangle Institute : Topoisomerase I inhibitor

Research Suggests Way to make Camptothecin More Tolerable to Patients (Doctor's Guide)
Summarizes research presented at the 11th annual NCI-EORTC-AACR symposium on new drugs in cancer therapy. Reports favorable results in pre-clinical and Phase I studies for camptothecin attached to polyethylene glycol (PEG). Notes that the Phase I studies included both SCLC and NSCLC patients.

Camptothecin - Recent MEDLINE Abstracts (PubMed)


Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2005, Lung Cancer Online Foundation
Last modified: 03-Nov-2005
Karen Parles, MLS Editor